Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90


The predicament of patients with suspected Ebola - Authors' reply.

Richardson ET, Fallah MP, Kelly JD, Barrie MB.

Lancet Glob Health. 2017 Jul;5(7):e660-e661. doi: 10.1016/S2214-109X(17)30210-3. No abstract available.


Herbert Barrie.

Barrie M.

BMJ. 2017 May 8;357:j2187. doi: 10.1136/bmj.j2187. No abstract available.


Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan.

Farina P, Tabouret E, Lehmann P, Barrie M, Petrirena G, Campello C, Boucard C, Graillon T, Girard N, Chinot O.

J Neurooncol. 2017 May;132(3):433-437. doi: 10.1007/s11060-017-2385-0. Epub 2017 Mar 6.


The Ebola suspect's dilemma.

Richardson ET, Barrie MB, Nutt CT, Kelly JD, Frankfurter R, Fallah MP, Farmer PE.

Lancet Glob Health. 2017 Mar;5(3):e254-e256. doi: 10.1016/S2214-109X(17)30041-4. No abstract available.


Emergency Medicine Resident Orientation: How Training Programs Get Their Residents Started.

McGrath J, Barrie M, Way DP.

West J Emerg Med. 2017 Jan;18(1):97-104. doi: 10.5811/westjem.2016.10.31275. Epub 2016 Nov 15.


Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.

Richardson ET, Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Marsh RH, Koedoyoma S, Daboh F, Barron KP, Grady M, Tucker E, Dierberg KL, Rutherford GW, Barry M, Jones JH, Murray MB, Farmer PE.

PLoS Negl Trop Dis. 2016 Nov 15;10(11):e0005087. doi: 10.1371/journal.pntd.0005087. eCollection 2016 Nov.


Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone.

Cancedda C, Davis SM, Dierberg KL, Lascher J, Kelly JD, Barrie MB, Koroma AP, George P, Kamara AA, Marsh R, Sumbuya MS, Nutt CT, Scott KW, Thomas E, Bollbach K, Sesay A, Barrie A, Barrera E, Barron K, Welch J, Bhadelia N, Frankfurter RG, Dahl OM, Das S, Rollins RE, Eustis B, Schwartz A, Pertile P, Pavlopoulos I, Mayfield A, Marsh RH, Dibba Y, Kloepper D, Hall A, Huster K, Grady M, Spray K, Walton DA, Daboh F, Nally C, James S, Warren GS, Chang J, Drasher M, Lamin G, Bangura S, Miller AC, Michaelis AP, McBain R, Broadhurst MJ, Murray M, Richardson ET, Philip T, Gottlieb GL, Mukherjee JS, Farmer PE.

J Infect Dis. 2016 Oct 15;214(suppl 3):S153-S163. Epub 2016 Sep 28.


Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life.

Baumstarck K, Leroy T, Hamidou Z, Tabouret E, Farina P, Barrié M, Campello C, Petrirena G, Chinot O, Auquier P.

J Neurooncol. 2016 Aug;129(1):155-64. doi: 10.1007/s11060-016-2161-6. Epub 2016 Jun 14.


The Majority of the Pre-Antiretroviral Population Who Were Lost to Follow-Up Stopped Their Care in Freetown, Sierra Leone: A 12-Month Prospective Cohort Study Starting with HIV Diagnosis.

Kelly JD, Schlough GW, Conteh S, Barrie MB, Kargbo B, Giordano TP.

PLoS One. 2016 Feb 22;11(2):e0149584. doi: 10.1371/journal.pone.0149584. eCollection 2016.


Pathology in Practice. Cardiac hemangiosarcoma in a snake.

Shoemaker M, Barrie M, Holman H, Wolk KE, Stromberg PC, Aeffner F.

J Am Vet Med Assoc. 2016 Jan 15;248(2):153-5. doi: 10.2460/javma.248.2.153. No abstract available.


Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.

Omuro A, Chinot O, Taillandier L, Ghesquieres H, Soussain C, Delwail V, Lamy T, Gressin R, Choquet S, Soubeyran P, Huchet A, Benouaich-Amiel A, Lebouvier-Sadot S, Gyan E, Touitou V, Barrié M, del Rio MS, Gonzalez-Aguilar A, Houillier C, Delgadillo D, Lacomblez L, Tanguy ML, Hoang-Xuan K.

Lancet Haematol. 2015 Jun;2(6):e251-9. doi: 10.1016/S2352-3026(15)00074-5. Epub 2015 Jun 3.


Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome.

Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D, Chinot O, Bruder N.

J Neurooncol. 2016 Mar;127(1):111-7. doi: 10.1007/s11060-015-2015-7. Epub 2015 Nov 25.


BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.

Tabouret E, Bequet C, Denicolaï E, Barrié M, Nanni I, Metellus P, Dufour H, Chinot O, Figarella-Branger D.

Eur J Surg Oncol. 2015 Dec;41(12):1685-90. doi: 10.1016/j.ejso.2015.09.012. Epub 2015 Sep 30.


MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma.

Tabouret E, Boudouresque F, Farina P, Barrié M, Bequet C, Sanson M, Chinot O.

Neuro Oncol. 2015 Aug;17(8):1174-6. doi: 10.1093/neuonc/nov094. No abstract available.


Relationships Between Dose Intensity, Toxicity, and Outcome in Patients with Oligodendroglial Tumors Treated with the PCV Regimen.

Tabouret E, Reyes-Botero G, Dehais C, Daros M, Barrie M, Matta M, Petrirena G, Autran D, Duran A, Bequet C, Delattre JY, Chinot O.

Anticancer Res. 2015 May;35(5):2901-8.


Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.

Lassen U, Chinot OL, McBain C, Mau-Sørensen M, Larsen VA, Barrie M, Roth P, Krieter O, Wang K, Habben K, Tessier J, Lahr A, Weller M.

Neuro Oncol. 2015 Jul;17(7):1007-15. doi: 10.1093/neuonc/nov019. Epub 2015 Feb 9.


Primary neurolymphomatosis diagnosis and treatment: a retrospective study.

Lagarde S, Tabouret E, Matta M, Franques J, Attarian S, Pouget J, Maues De Paula A, Figarella-Branger D, Dory-Lautrec P, Chinot O, Barrié M.

J Neurol Sci. 2014 Jul 15;342(1-2):178-81. doi: 10.1016/j.jns.2014.04.030. Epub 2014 May 1.


Bing-Neel syndrome: a cerebral Richter syndrome?

Tabouret E, Coso D, Matta M, Barrié M, Bouabdallah R, Chinot O.

Neurol India. 2014 Mar-Apr;62(2):229-30. doi: 10.4103/0028-3886.132451. No abstract available.


Monteggia lesion in an Asian small-clawed otter (Aonyx cinerea).

Peters HJ, Hettlich BF, Barrie MT.

J Zoo Wildl Med. 2013 Dec;44(4):1063-7.


Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.

Tabouret E, Boudouresque F, Barrie M, Matta M, Boucard C, Loundou A, Carpentier A, Sanson M, Metellus P, Figarella-Branger D, Ouafik L, Chinot O.

Neuro Oncol. 2014 Mar;16(3):392-9. doi: 10.1093/neuonc/not226. Epub 2013 Dec 9.

Supplemental Content

Loading ...
Support Center